UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934 (Amendment No. 13) ORTHOMETRIX, INC. (Name of Issuer) Common Stock, $.0005 par value (Title of Class of Securities) 68750M-10-0 (CUSIP Number) Reynald G. Bonmati Premium Point New Rochelle, NY 10801 (914) 576-1595 (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications) February 2, 2006 (Date of Event which Requires Filing of this Statement) If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of ss.ss.240.13d-1(e), 240.13d-1(f) or 240.13d-2(g), check the following box [ ]. Note: Schedules filed in paper format shall include a signed original and five copies of this schedule, including all exhibits, should be filed with the Commission. See ss.240.13d-7(b) for other parties to whom copies are to be sent. * The remainder of this cover page shall be filled out for a person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page. The information required on the remainder of this cover page shall not be deemed "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). SCHEDULE 13D -------------------------------------------------------------------------------- 1 NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) REYNALD G. BONMATI -------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) (a) ( ) (b) (X) -------------------------------------------------------------------------------- 3 SEC USE ONLY -------------------------------------------------------------------------------- 4 SOURCE OF FUNDS (SEE INSTRUCTIONS) PF -------------------------------------------------------------------------------- 5 CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e) ( ) -------------------------------------------------------------------------------- 6 CITIZENSHIP OR PLACE OF ORGANIZATION U.S. CITIZEN -------------------------------------------------------------------------------- 7 SOLE VOTING POWER 6,929,670 ----------------------------------------------------------------- NUMBER OF 8 SHARED VOTING POWER SHARES BENEFICIALLY 13,359,499 OWNED BY EACH ----------------------------------------------------------------- REPORTING 9 SOLE DISPOSITIVE POWER PERSON WITH 6,929,670 ----------------------------------------------------------------- 10 SHARED DISPOSITIVE POWER 13,359,499 -------------------------------------------------------------------------------- 11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 21,534,557 -------------------------------------------------------------------------------- 12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) ( ) -------------------------------------------------------------------------------- 13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 48.6% -------------------------------------------------------------------------------- 14 TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) IN -------------------------------------------------------------------------------- Statement on Schedule 13D/A This Amendment amends the Statement on Schedule 13D of the undersigned filed with the Securities and Exchange Commission on August 4, 2000 (the "Original Statement") with respect to the beneficial ownership by such person of shares of common stock, $.0005 par value ("Common Stock"), of Orthometrix, Inc., a Delaware corporation (the "Issuer"). The filing of this Amendment is occasioned by an exercise of stock options for Common Stock of the Issuer by Mr. Bonmati. Except as set forth herein, the information provided in the original statement is unchanged. ITEM 1. SECURITY AND ISSUER. This statement relates to the Common Stock of the Issuer, Orthometrix, Inc. The principal executive office of the Issuer is located at 106 Corporate Park Drive, Suite 102, White Plains, New York 10604. ITEM 2. IDENTITY AND BACKGROUND. The person filing this statement is Reynald G. Bonmati, whose residence address is Premium Point, New Rochelle, New York 10801. The undersigned is Chairman of the Board, President, Treasurer and a Director of the Company. The undersigned is also a managing member of Bones, LLC an entity which is a stockholder of the Issuer. During the past five years, the foregoing party, has not (a) been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors), or (b) been party to a civil proceeding of a judicial or administrative body of competent jurisdiction and as a result of such proceeding was or is subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws, or finding any violations with respect to such laws. ITEM 3. SOURCE AND AMOUNT OF FUNDS OR OTHER CONSIDERATION. Mr. Bonmati exercised stock options in the amount of $17,046 for its purchase of 146,250 shares of Common Stock of the Issuer on February 2, 2006. ITEM 4. PURPOSE OF TRANSACTION. This Amendment is being filed as a result of the transactions described above. The reporting persons have no present plans or proposals that relate to or would result in or cause: (a) the acquisition by any person of additional securities of the Issuer, or the disposition of securities of the Issuer; (b) an extraordinary corporate transaction, such as a merger, reorganization or liquidation, involving the Issuer or any of its subsidiaries; (c) a sale or transfer of a material amount of assets of the Issuer or any of its subsidiaries; (d) any change in the present board of directors or management of the Issuer, including any plans or proposals to change the number or term of directors or to fill any existing vacancies on the board; (e) any material change in the present capitalization or dividend policy of the Issuer; (f) any other material change in the Issuer's business or corporate structure; (g) changes in the Issuer's charter, bylaws or instruments corresponding thereto or other actions which may impede the acquisition of control of the Issuer by any person; (h) a class of securities of the Issuer being de-listed from a national securities exchange or to cease to be authorized to be quoted in an interdealer quotation system of a registered national securities association; (i) a class of equity securities of the Issuer becoming eligible for termination of registration pursuant to Section 12(g)(4)of the Securities Exchange Act of 1934; or (j) any action similar to any of those enumerated above. The filing person reserves the right to adopt such plans and proposals subject to applicable regulatory requirements, if any; and to transfer securities of the Issuer directly and/or sell securities of the Issuer in the open market. ITEM 5. INTEREST IN SECURITIES OF THE ISSUER. (a) As of February 10, 2006, there were 44,353,618 shares of Common Stock of the Issuer outstanding. Mr. Bonmati may be deemed to be the beneficial owner of 21,534,557 shares of Common Stock (or 48.6% of the total shares outstanding). This figure includes: (i) 6,929,670 shares owned directly by Mr. Bonmati; and (ii) 13,359,499 shares owned directly by Bones, LLC and indirectly by Mr. Bonmati. Mr. Bonmati may be deemed to beneficially own the shares owned by Bones LLC due to his relationship with such entity. Mr. Bonmati is a managing member of Bones LLC. Beneficial ownership of the stock owned by Bones is disclaimed by Mr. Bonmati, except to the extent of his proportionate interest in such entities. Mr. Bonmati disclaims beneficial ownership for 1,391,638 shares of Common Stock; of which 1,361,638 shares are owned by Mr. Bonmati's wife, as trustee of the Sandrine Bonmati Trust and The Chrystele Bonmati Trust benefiting their children, and 30,000 shares are owned by Mr. Bonmati's granddaughters. (b) Mr. Bonmati has sole power to vote and dispose of 6,929,670 shares owned directly by Mr. Bonmati and shared power to vote and dispose of 13,359,499 shares owned by Bones LLC. (c) There have been no transactions in securities of the Company affected during the past sixty days by the undersigned other than as described herein. (d) Except as set forth in this Amended Statement, no other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the securities of, the Issuer that are owned beneficially by the reporting persons. (e) Item 5(e) is not applicable to this Amended Statement. ITEM 6. CONTRACTS, ARRANGEMENTS, UNDERSTANDINGS OR RELATIONSHIPS WITH RESPECT TO THE SECURITIES OF THE COMPANY N/A ITEM 7. MATERIAL TO BE FILED AS EXHIBITS. N/A SIGNATURES After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Date: February 13, 2006 /s/ Reynald G. Bonmati -------------------------- Reynald G. Bonmati President and Chairman